David H. Mack

2021

In 2021, David H. Mack earned a total compensation of $3.5M as President, Chief Executive Officer and Director at PMV Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$343,750
Option Awards$2,652,651
Salary$545,454
Total$3,541,855

Mack received $2.7M in option awards, accounting for 75% of the total pay in 2021.

Mack also received $343.8K in non-equity incentive plan and $545.5K in salary.

Rankings

In 2021, David H. Mack's compensation ranked 3,770th out of 12,415 executives tracked by ExecPay. In other words, Mack earned more than 69.6% of executives.

ClassificationRankingPercentile
All
3,770
out of 12,415
70th
Division
Manufacturing
1,540
out of 5,505
72nd
Major group
Chemicals And Allied Products
625
out of 2,375
74th
Industry group
Drugs
554
out of 2,096
74th
Industry
Pharmaceutical Preparations
388
out of 1,546
75th
Source: SEC filing on April 28, 2023.

Mack's colleagues

We found two more compensation records of executives who worked with David H. Mack at PMV Pharmaceuticals in 2021.

2021

Winston Kung

PMV Pharmaceuticals

Chief Financial Officer

2021

Leila Alland

PMV Pharmaceuticals

Chief Medical Officer

News

In-depth

You may also like